NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) reported Q2 EPS of ($0.12), $0.01 better than the analyst estimate of ($0.13).

For earnings history and earnings-related data on NRx Pharmaceuticals, Inc. (NRXP) click here.